Debbie Hart
Chair at the Commission on Science, Innovation and Technology (CSIT) @ NJEDA
Trenton, United States
Debbie Hart is a grant investor at NJEDA in Trenton focused on Biotechnology and Software. Debbie Hart is the current President and CEO of BioNJ. Debbie Hart attended Syracuse University.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Debbie Hart invests in
Stages Debbie Hart invests in
Countries Debbie Hart invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 4 (33%)
- Software 3 (25%)
- Health Care 3 (25%)
- Medical 2 (17%)
- Life Science 2 (17%)
Country
- United States 11 (92%)
- Trinidad and Tobago 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SingletO2 Therapeutics creates new treatments for periodontal disease using singlet oxygen. The company was founded in 2015 and is headquartered in New Providence, New Jersey. | $25K / Grant / Feb 16, 2023 | ||
| Shock Tech designs, manufactures, and tests shock attenuation and vibration isolation systems for the most demanding environments. They provide solutions for customer equipment’s dynamic protection problems. They also offer technical support and rapid prototyping services. | $25K / Grant / Feb 16, 2023 | ||
| Regenosine is a healthcare center that provides products that include regenerating cartilage and joint preservation. An online inquiry form is available on the company's website. | $25K / Grant / Feb 16, 2023 | ||
| Farm to Flame Energy produces biomass-powered generators created to use one or two feedstocks to power their engines. Founded in 2018, it offers electrical generators, ongoing fueling, monitoring service, and blockchain-based application, enabling clients to remotely access generators. | $25K / Grant / Feb 16, 2023 | ||
|
Venarum Medical
|
Venarum Medical creates endovascular solutions for severe vascular problems, such as deep vein chronic venous insufficiency. They provide catheter-delivered implants for a prosthetic venous valve and a urine incontinence device. | $50K / Grant / Feb 16, 2023 | |
| Innovative AI Technology offers a platform that serves as a springboard for NJIT graduates' creative ideas. | $25K / Grant / Feb 16, 2023 | ||
| AuresTech is committed to providing customers with robust technical solutions, and they always strive to deliver solutions to the most difficult problems. They provide systems engineering, field programmable gate array, and machine learning services. | $25K / Grant / Feb 16, 2023 | ||
| Paragon Flavors is a food company. They seeking to develop better natural ingredients that fit the needs of modern foods. They have within flavor encapsulation, process engineering, physical chemistry, as well as navigating food ingredient regulatory spaces. | $25K / Grant / Feb 16, 2023 | ||
| Bezwada Biomedical is a medical company that specializes in biomedical absorbable polymers. The company was established in 2003 and is based in Hillsborough, New Jersey. | $50K / Grant / Feb 16, 2023 | ||
| Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens. | $25K / Grant / Feb 16, 2023 | ||
| See all 12 investments → | |||
Co-Investors
About NJEDA
NJEDA is a government entity assisting and giving access to capital, including tax-exempt and taxable bond financing. It also offers loans, loan guarantees, and business and tax incentives. In addition, it offers real estate development assistance and technology facilities. In 1974, John Smith established it in Trenton, New Jersey.
NJEDA Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Frederick J. Cole
Senior Vice President- Operations
|
|||
Lori Matheus
Senior Vice President- Finance & Development
|
|||
|
Debbie Hart
Chair at the Commission on Science, Innovation and Technology (CSIT)
|
|||
Emma Corrado
Deputy Chief Operating Officer
|
|||
Evan Weiss
President and CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Debbie Hart invest in?
Debbie Hart invests primarily in Biotechnology, Software and Health Care startups, most often at Grant stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Debbie Hart?
Public channels for Debbie Hart include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Debbie Hart last invest?
The most recent investment recorded for Debbie Hart closed in Feb 2023. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
